BRAF and cutaneous melanoma: Since the discovery of gain of function mutations in the proto-oncogenes NRAS [1] and BRAF [2], thousands of human skin melanoma samples have been analyzed, and the estimated incidence of NRAS and BRAF mutations are 18 % and 41 %, respectively [3].